acetylcarnitine has been researched along with vasoactive intestinal peptide in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bertelli, A; Di Giulio, AM; Donadoni, L; Germani, E; Gorio, A; Maccari, F; Mantegazza, P; Ramacci, MT; Tenconi, B | 1 |
| Bazotte, RB; de Miranda-Neto, MH; Defani, MA; Natali, MR; Zanoni, JN | 1 |
2 other study(ies) available for acetylcarnitine and vasoactive intestinal peptide
| Article | Year |
|---|---|
Peptide alterations in autonomic diabetic neuropathy prevented by acetyl-L-carnitine.
Topics: Acetylcarnitine; Animals; Autonomic Nervous System Diseases; Diabetes Mellitus, Experimental; Diabetic Neuropathies; Enkephalin, Methionine; Intestinal Mucosa; Intestines; Male; Neuropeptides; Rats; Rats, Sprague-Dawley; Substance P; Vasoactive Intestinal Peptide | 1992 |
Effect of acetyl-L-carnitine on VIP-ergic neurons in the jejunum submucous plexus of diabetic rats.
Topics: Acetylcarnitine; Animals; Blood Glucose; Diabetes Mellitus, Experimental; Diabetic Neuropathies; Dietary Supplements; Immunohistochemistry; Jejunum; Male; Neurons; Nootropic Agents; Rats; Rats, Wistar; Streptozocin; Submucous Plexus; Vasoactive Intestinal Peptide | 2003 |